Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for G-CSF Biosimilars in US$ by the following Product Segments: Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor
Company profiles are primarily based on public domain information including company
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Pfizer
Novartis
Roche
Market Analysis and Insights: Global G-CSF Biosimilars Market
The global G-CSF Biosimilars market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global G-CSF Biosimilars Scope and Segment
The global G-CSF Biosimilars market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global G-CSF Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
By the end users/application, this report covers the following segments
Blood Disorders
Oncology Diseases
Chronic And Autoimmune Diseases
Growth Hormone Deficiencies
Competitive Landscape:
The report provides a list of all the key players in the G-CSF Biosimilars market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The G-CSF Biosimilars key manufacturers in this market include:
Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for G-CSF Biosimilars in US$ by the following Product Segments: Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor
Company profiles are primarily based on public domain information including company
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Pfizer
Novartis
Roche
Market Analysis and Insights: Global G-CSF Biosimilars Market
The global G-CSF Biosimilars market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global G-CSF Biosimilars Scope and Segment
The global G-CSF Biosimilars market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global G-CSF Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
By the end users/application, this report covers the following segments
Blood Disorders
Oncology Diseases
Chronic And Autoimmune Diseases
Growth Hormone Deficiencies
Competitive Landscape:
The report provides a list of all the key players in the G-CSF Biosimilars market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The G-CSF Biosimilars key manufacturers in this market include:
Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
1 G-CSF Biosimilars Market Overview
1.1 G-CSF Biosimilars Product Overview
1.2 G-CSF Biosimilars Market Segment by Type
1.2.1 Human Growth Hormone
1.2.2 Erythropoietin
1.2.3 Monoclonal Antibodies
1.2.4 Insulin
1.2.5 Interferon
1.2.6 Granulocyte-Colony Stimulating Factor
1.3 Global G-CSF Biosimilars Market Size by Type
1.3.1 Global G-CSF Biosimilars Market Size Overview by Type (2016-2027)
1.3.2 Global G-CSF Biosimilars Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global G-CSF Biosimilars Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global G-CSF Biosimilars Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global G-CSF Biosimilars Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global G-CSF Biosimilars Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global G-CSF Biosimilars Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global G-CSF Biosimilars Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global G-CSF Biosimilars Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America G-CSF Biosimilars Sales Breakdown by Type (2016-2021)
1.4.2 Europe G-CSF Biosimilars Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific G-CSF Biosimilars Sales Breakdown by Type (2016-2021)
1.4.4 Latin America G-CSF Biosimilars Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa G-CSF Biosimilars Sales Breakdown by Type (2016-2021)
2 Global G-CSF Biosimilars Market Competition by Company
2.1 Global Top Players by G-CSF Biosimilars Sales (2016-2021)
2.2 Global Top Players by G-CSF Biosimilars Revenue (2016-2021)
2.3 Global Top Players G-CSF Biosimilars Price (2016-2021)
2.4 Global Top Manufacturers G-CSF Biosimilars Manufacturing Base Distribution, Sales Area, Product Type
2.5 G-CSF Biosimilars Market Competitive Situation and Trends
2.5.1 G-CSF Biosimilars Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by G-CSF Biosimilars Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in G-CSF Biosimilars as of 2020)
2.7 Date of Key Manufacturers Enter into G-CSF Biosimilars Market
2.8 Key Manufacturers G-CSF Biosimilars Product Offered
2.9 Mergers & Acquisitions, Expansion
3 G-CSF Biosimilars Status and Outlook by Region
3.1 Global G-CSF Biosimilars Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global G-CSF Biosimilars Historic Market Size by Region
3.2.1 Global G-CSF Biosimilars Sales in Volume by Region (2016-2021)
3.2.2 Global G-CSF Biosimilars Sales in Value by Region (2016-2021)
3.2.3 Global G-CSF Biosimilars Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global G-CSF Biosimilars Forecasted Market Size by Region
3.3.1 Global G-CSF Biosimilars Sales in Volume by Region (2022-2027)
3.3.2 Global G-CSF Biosimilars Sales in Value by Region (2022-2027)
3.3.3 Global G-CSF Biosimilars Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global G-CSF Biosimilars by Application
4.1 G-CSF Biosimilars Market Segment by Application
4.1.1 Blood Disorders
4.1.2 Oncology Diseases
4.1.3 Chronic And Autoimmune Diseases
4.1.4 Growth Hormone Deficiencies
4.2 Global G-CSF Biosimilars Market Size by Application
4.2.1 Global G-CSF Biosimilars Market Size Overview by Application (2016-2027)
4.2.2 Global G-CSF Biosimilars Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global G-CSF Biosimilars Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global G-CSF Biosimilars Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global G-CSF Biosimilars Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global G-CSF Biosimilars Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global G-CSF Biosimilars Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global G-CSF Biosimilars Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global G-CSF Biosimilars Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America G-CSF Biosimilars Sales Breakdown by Application (2016-2021)
4.3.2 Europe G-CSF Biosimilars Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific G-CSF Biosimilars Sales Breakdown by Application (2016-2021)
4.3.4 Latin America G-CSF Biosimilars Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa G-CSF Biosimilars Sales Breakdown by Application (2016-2021)
5 North America G-CSF Biosimilars by Country
5.1 North America G-CSF Biosimilars Historic Market Size by Country
5.1.1 North America G-CSF Biosimilars Sales in Volume by Country (2016-2021)
5.1.2 North America G-CSF Biosimilars Sales in Value by Country (2016-2021)
5.2 North America G-CSF Biosimilars Forecasted Market Size by Country
5.2.1 North America G-CSF Biosimilars Sales in Volume by Country (2022-2027)
5.2.2 North America G-CSF Biosimilars Sales in Value by Country (2022-2027)
6 Europe G-CSF Biosimilars by Country
6.1 Europe G-CSF Biosimilars Historic Market Size by Country
6.1.1 Europe G-CSF Biosimilars Sales in Volume by Country (2016-2021)
6.1.2 Europe G-CSF Biosimilars Sales in Value by Country (2016-2021)
6.2 Europe G-CSF Biosimilars Forecasted Market Size by Country
6.2.1 Europe G-CSF Biosimilars Sales in Volume by Country (2022-2027)
6.2.2 Europe G-CSF Biosimilars Sales in Value by Country (2022-2027)
7 Asia-Pacific G-CSF Biosimilars by Region
7.1 Asia-Pacific G-CSF Biosimilars Historic Market Size by Region
7.1.1 Asia-Pacific G-CSF Biosimilars Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific G-CSF Biosimilars Sales in Value by Region (2016-2021)
7.2 Asia-Pacific G-CSF Biosimilars Forecasted Market Size by Region
7.2.1 Asia-Pacific G-CSF Biosimilars Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific G-CSF Biosimilars Sales in Value by Region (2022-2027)
8 Latin America G-CSF Biosimilars by Country
8.1 Latin America G-CSF Biosimilars Historic Market Size by Country
8.1.1 Latin America G-CSF Biosimilars Sales in Volume by Country (2016-2021)
8.1.2 Latin America G-CSF Biosimilars Sales in Value by Country (2016-2021)
8.2 Latin America G-CSF Biosimilars Forecasted Market Size by Country
8.2.1 Latin America G-CSF Biosimilars Sales in Volume by Country (2022-2027)
8.2.2 Latin America G-CSF Biosimilars Sales in Value by Country (2022-2027)
9 Middle East and Africa G-CSF Biosimilars by Country
9.1 Middle East and Africa G-CSF Biosimilars Historic Market Size by Country
9.1.1 Middle East and Africa G-CSF Biosimilars Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa G-CSF Biosimilars Sales in Value by Country (2016-2021)
9.2 Middle East and Africa G-CSF Biosimilars Forecasted Market Size by Country
9.2.1 Middle East and Africa G-CSF Biosimilars Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa G-CSF Biosimilars Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in G-CSF Biosimilars Business
10.1 Pfizer
10.1.1 Pfizer Corporation Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Pfizer G-CSF Biosimilars Products Offered
10.1.5 Pfizer Recent Development
10.2 Novartis
10.2.1 Novartis Corporation Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Pfizer G-CSF Biosimilars Products Offered
10.2.5 Novartis Recent Development
10.3 Roche
10.3.1 Roche Corporation Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Roche G-CSF Biosimilars Products Offered
10.3.5 Roche Recent Development
10.4 Merck & Co.
10.4.1 Merck & Co. Corporation Information
10.4.2 Merck & Co. Introduction and Business Overview
10.4.3 Merck & Co. G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Merck & Co. G-CSF Biosimilars Products Offered
10.4.5 Merck & Co. Recent Development
10.5 Sanofi
10.5.1 Sanofi Corporation Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Sanofi G-CSF Biosimilars Products Offered
10.5.5 Sanofi Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Corporation Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Johnson & Johnson G-CSF Biosimilars Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Gilead Science
10.7.1 Gilead Science Corporation Information
10.7.2 Gilead Science Introduction and Business Overview
10.7.3 Gilead Science G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Gilead Science G-CSF Biosimilars Products Offered
10.7.5 Gilead Science Recent Development
10.8 GlaxoSmithKline
10.8.1 GlaxoSmithKline Corporation Information
10.8.2 GlaxoSmithKline Introduction and Business Overview
10.8.3 GlaxoSmithKline G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.8.4 GlaxoSmithKline G-CSF Biosimilars Products Offered
10.8.5 GlaxoSmithKline Recent Development
10.9 AbbVie
10.9.1 AbbVie Corporation Information
10.9.2 AbbVie Introduction and Business Overview
10.9.3 AbbVie G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.9.4 AbbVie G-CSF Biosimilars Products Offered
10.9.5 AbbVie Recent Development
10.10 Amgen
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 G-CSF Biosimilars Product Category, Application and Specification
10.10.3 Amgen G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Amgen Recent Development
10.11 AstraZeneca
10.11.1 AstraZeneca Corporation Information
10.11.2 AstraZeneca Introduction and Business Overview
10.11.3 AstraZeneca G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.11.4 AstraZeneca G-CSF Biosimilars Products Offered
10.11.5 AstraZeneca Recent Development
10.12 Bayer
10.12.1 Bayer Corporation Information
10.12.2 Bayer Introduction and Business Overview
10.12.3 Bayer G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Bayer G-CSF Biosimilars Products Offered
10.12.5 Bayer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 G-CSF Biosimilars Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 G-CSF Biosimilars Industrial Chain Analysis
11.4 G-CSF Biosimilars Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 G-CSF Biosimilars Distributors
12.3 G-CSF Biosimilars Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 G-CSF Biosimilars Product Overview
1.2 G-CSF Biosimilars Market Segment by Type
1.2.1 Human Growth Hormone
1.2.2 Erythropoietin
1.2.3 Monoclonal Antibodies
1.2.4 Insulin
1.2.5 Interferon
1.2.6 Granulocyte-Colony Stimulating Factor
1.3 Global G-CSF Biosimilars Market Size by Type
1.3.1 Global G-CSF Biosimilars Market Size Overview by Type (2016-2027)
1.3.2 Global G-CSF Biosimilars Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global G-CSF Biosimilars Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global G-CSF Biosimilars Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global G-CSF Biosimilars Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global G-CSF Biosimilars Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global G-CSF Biosimilars Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global G-CSF Biosimilars Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global G-CSF Biosimilars Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America G-CSF Biosimilars Sales Breakdown by Type (2016-2021)
1.4.2 Europe G-CSF Biosimilars Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific G-CSF Biosimilars Sales Breakdown by Type (2016-2021)
1.4.4 Latin America G-CSF Biosimilars Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa G-CSF Biosimilars Sales Breakdown by Type (2016-2021)
2 Global G-CSF Biosimilars Market Competition by Company
2.1 Global Top Players by G-CSF Biosimilars Sales (2016-2021)
2.2 Global Top Players by G-CSF Biosimilars Revenue (2016-2021)
2.3 Global Top Players G-CSF Biosimilars Price (2016-2021)
2.4 Global Top Manufacturers G-CSF Biosimilars Manufacturing Base Distribution, Sales Area, Product Type
2.5 G-CSF Biosimilars Market Competitive Situation and Trends
2.5.1 G-CSF Biosimilars Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by G-CSF Biosimilars Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in G-CSF Biosimilars as of 2020)
2.7 Date of Key Manufacturers Enter into G-CSF Biosimilars Market
2.8 Key Manufacturers G-CSF Biosimilars Product Offered
2.9 Mergers & Acquisitions, Expansion
3 G-CSF Biosimilars Status and Outlook by Region
3.1 Global G-CSF Biosimilars Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global G-CSF Biosimilars Historic Market Size by Region
3.2.1 Global G-CSF Biosimilars Sales in Volume by Region (2016-2021)
3.2.2 Global G-CSF Biosimilars Sales in Value by Region (2016-2021)
3.2.3 Global G-CSF Biosimilars Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global G-CSF Biosimilars Forecasted Market Size by Region
3.3.1 Global G-CSF Biosimilars Sales in Volume by Region (2022-2027)
3.3.2 Global G-CSF Biosimilars Sales in Value by Region (2022-2027)
3.3.3 Global G-CSF Biosimilars Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global G-CSF Biosimilars by Application
4.1 G-CSF Biosimilars Market Segment by Application
4.1.1 Blood Disorders
4.1.2 Oncology Diseases
4.1.3 Chronic And Autoimmune Diseases
4.1.4 Growth Hormone Deficiencies
4.2 Global G-CSF Biosimilars Market Size by Application
4.2.1 Global G-CSF Biosimilars Market Size Overview by Application (2016-2027)
4.2.2 Global G-CSF Biosimilars Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global G-CSF Biosimilars Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global G-CSF Biosimilars Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global G-CSF Biosimilars Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global G-CSF Biosimilars Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global G-CSF Biosimilars Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global G-CSF Biosimilars Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global G-CSF Biosimilars Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America G-CSF Biosimilars Sales Breakdown by Application (2016-2021)
4.3.2 Europe G-CSF Biosimilars Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific G-CSF Biosimilars Sales Breakdown by Application (2016-2021)
4.3.4 Latin America G-CSF Biosimilars Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa G-CSF Biosimilars Sales Breakdown by Application (2016-2021)
5 North America G-CSF Biosimilars by Country
5.1 North America G-CSF Biosimilars Historic Market Size by Country
5.1.1 North America G-CSF Biosimilars Sales in Volume by Country (2016-2021)
5.1.2 North America G-CSF Biosimilars Sales in Value by Country (2016-2021)
5.2 North America G-CSF Biosimilars Forecasted Market Size by Country
5.2.1 North America G-CSF Biosimilars Sales in Volume by Country (2022-2027)
5.2.2 North America G-CSF Biosimilars Sales in Value by Country (2022-2027)
6 Europe G-CSF Biosimilars by Country
6.1 Europe G-CSF Biosimilars Historic Market Size by Country
6.1.1 Europe G-CSF Biosimilars Sales in Volume by Country (2016-2021)
6.1.2 Europe G-CSF Biosimilars Sales in Value by Country (2016-2021)
6.2 Europe G-CSF Biosimilars Forecasted Market Size by Country
6.2.1 Europe G-CSF Biosimilars Sales in Volume by Country (2022-2027)
6.2.2 Europe G-CSF Biosimilars Sales in Value by Country (2022-2027)
7 Asia-Pacific G-CSF Biosimilars by Region
7.1 Asia-Pacific G-CSF Biosimilars Historic Market Size by Region
7.1.1 Asia-Pacific G-CSF Biosimilars Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific G-CSF Biosimilars Sales in Value by Region (2016-2021)
7.2 Asia-Pacific G-CSF Biosimilars Forecasted Market Size by Region
7.2.1 Asia-Pacific G-CSF Biosimilars Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific G-CSF Biosimilars Sales in Value by Region (2022-2027)
8 Latin America G-CSF Biosimilars by Country
8.1 Latin America G-CSF Biosimilars Historic Market Size by Country
8.1.1 Latin America G-CSF Biosimilars Sales in Volume by Country (2016-2021)
8.1.2 Latin America G-CSF Biosimilars Sales in Value by Country (2016-2021)
8.2 Latin America G-CSF Biosimilars Forecasted Market Size by Country
8.2.1 Latin America G-CSF Biosimilars Sales in Volume by Country (2022-2027)
8.2.2 Latin America G-CSF Biosimilars Sales in Value by Country (2022-2027)
9 Middle East and Africa G-CSF Biosimilars by Country
9.1 Middle East and Africa G-CSF Biosimilars Historic Market Size by Country
9.1.1 Middle East and Africa G-CSF Biosimilars Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa G-CSF Biosimilars Sales in Value by Country (2016-2021)
9.2 Middle East and Africa G-CSF Biosimilars Forecasted Market Size by Country
9.2.1 Middle East and Africa G-CSF Biosimilars Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa G-CSF Biosimilars Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in G-CSF Biosimilars Business
10.1 Pfizer
10.1.1 Pfizer Corporation Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Pfizer G-CSF Biosimilars Products Offered
10.1.5 Pfizer Recent Development
10.2 Novartis
10.2.1 Novartis Corporation Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Pfizer G-CSF Biosimilars Products Offered
10.2.5 Novartis Recent Development
10.3 Roche
10.3.1 Roche Corporation Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Roche G-CSF Biosimilars Products Offered
10.3.5 Roche Recent Development
10.4 Merck & Co.
10.4.1 Merck & Co. Corporation Information
10.4.2 Merck & Co. Introduction and Business Overview
10.4.3 Merck & Co. G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Merck & Co. G-CSF Biosimilars Products Offered
10.4.5 Merck & Co. Recent Development
10.5 Sanofi
10.5.1 Sanofi Corporation Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Sanofi G-CSF Biosimilars Products Offered
10.5.5 Sanofi Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Corporation Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Johnson & Johnson G-CSF Biosimilars Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Gilead Science
10.7.1 Gilead Science Corporation Information
10.7.2 Gilead Science Introduction and Business Overview
10.7.3 Gilead Science G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Gilead Science G-CSF Biosimilars Products Offered
10.7.5 Gilead Science Recent Development
10.8 GlaxoSmithKline
10.8.1 GlaxoSmithKline Corporation Information
10.8.2 GlaxoSmithKline Introduction and Business Overview
10.8.3 GlaxoSmithKline G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.8.4 GlaxoSmithKline G-CSF Biosimilars Products Offered
10.8.5 GlaxoSmithKline Recent Development
10.9 AbbVie
10.9.1 AbbVie Corporation Information
10.9.2 AbbVie Introduction and Business Overview
10.9.3 AbbVie G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.9.4 AbbVie G-CSF Biosimilars Products Offered
10.9.5 AbbVie Recent Development
10.10 Amgen
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 G-CSF Biosimilars Product Category, Application and Specification
10.10.3 Amgen G-CSF Biosimilars Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Amgen Recent Development
10.11 AstraZeneca
10.11.1 AstraZeneca Corporation Information
10.11.2 AstraZeneca Introduction and Business Overview
10.11.3 AstraZeneca G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.11.4 AstraZeneca G-CSF Biosimilars Products Offered
10.11.5 AstraZeneca Recent Development
10.12 Bayer
10.12.1 Bayer Corporation Information
10.12.2 Bayer Introduction and Business Overview
10.12.3 Bayer G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Bayer G-CSF Biosimilars Products Offered
10.12.5 Bayer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 G-CSF Biosimilars Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 G-CSF Biosimilars Industrial Chain Analysis
11.4 G-CSF Biosimilars Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 G-CSF Biosimilars Distributors
12.3 G-CSF Biosimilars Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
